O. Leitner

833 total citations
9 papers, 728 citations indexed

About

O. Leitner is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Dermatology. According to data from OpenAlex, O. Leitner has authored 9 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Molecular Biology and 2 papers in Dermatology. Recurrent topics in O. Leitner's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Skin and Cellular Biology Research (2 papers) and Immunotherapy and Immune Responses (2 papers). O. Leitner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Skin and Cellular Biology Research (2 papers) and Immunotherapy and Immune Responses (2 papers). O. Leitner collaborates with scholars based in Israel and United States. O. Leitner's co-authors include Hartmut Engelmann, David Wallach, Yosef Yarden, Eran Hadas, Yonat Shemer Avni, I Sarov, Helmut Holtmann, Y. Nophar, Cord Brakebusch and Ilana Stancovski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer.

In The Last Decade

O. Leitner

9 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Leitner Israel 9 370 311 252 214 76 9 728
Arnaud Dupuy d’Angeac France 11 410 1.1× 251 0.8× 169 0.7× 105 0.5× 74 1.0× 28 886
A Nilson United States 17 518 1.4× 261 0.8× 117 0.5× 221 1.0× 80 1.1× 23 785
Kevin B. Leslie Canada 12 335 0.9× 494 1.6× 236 0.9× 108 0.5× 48 0.6× 16 919
A. Miyajima Japan 14 452 1.2× 348 1.1× 223 0.9× 100 0.5× 38 0.5× 27 992
S. D. Abbot United Kingdom 11 493 1.3× 231 0.7× 287 1.1× 112 0.5× 57 0.8× 13 934
Liang‐Ji Zhou United States 9 781 2.1× 320 1.0× 205 0.8× 146 0.7× 76 1.0× 10 1.1k
Ennan Guan United States 13 409 1.1× 300 1.0× 237 0.9× 57 0.3× 62 0.8× 15 755
M Sharon United States 10 1.0k 2.7× 184 0.6× 267 1.1× 173 0.8× 55 0.7× 13 1.2k
Lawrence W. Morrissey United States 12 351 0.9× 345 1.1× 177 0.7× 65 0.3× 110 1.4× 16 832
Srinivas Mamidi Germany 14 485 1.3× 391 1.3× 177 0.7× 112 0.5× 53 0.7× 21 868

Countries citing papers authored by O. Leitner

Since Specialization
Citations

This map shows the geographic impact of O. Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Leitner more than expected).

Fields of papers citing papers by O. Leitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Leitner. The network helps show where O. Leitner may publish in the future.

Co-authorship network of co-authors of O. Leitner

This figure shows the co-authorship network connecting the top 25 collaborators of O. Leitner. A scholar is included among the top collaborators of O. Leitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Leitner. O. Leitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Rubinstein, Daniel B., Ravit Ziv, Itai Benhar, et al.. (2006). MUC1/X Protein Immunization Enhances cDNA Immunization in Generating Anti-MUC1 α/β Junction Antibodies that Target Malignant Cells. Cancer Research. 66(23). 11247–11253. 19 indexed citations
2.
Shalitin, Dror, Munir Mawassi, Ron Gafny, et al.. (1994). Serological characterisation of citrus tristeza virus isolates from Israel. Annals of Applied Biology. 125(1). 105–113. 9 indexed citations
3.
Blechman, Janna, Sima Lev, Maria Felice Brizzi, et al.. (1993). Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor.. Journal of Biological Chemistry. 268(6). 4399–4406. 58 indexed citations
4.
Novick, Daniela, Hartmut Engelmann, Michel Revel, O. Leitner, & Menachem Rubinstein. (1991). Monoclonal Antibodies to the Soluble Human IL-6 Receptor: Affinity Purification, ELISA, and Inhibition of Ligand Binding. Hybridoma. 10(1). 137–146. 40 indexed citations
5.
Stancovski, Ilana, Esther Hurwitz, O. Leitner, et al.. (1991). Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth.. Proceedings of the National Academy of Sciences. 88(19). 8691–8695. 180 indexed citations
7.
Novick, Daniela, Hartmut Engelmann, David Wallach, et al.. (1990). Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. Journal of Chromatography A. 510. 331–337. 60 indexed citations
8.
Engelmann, Hartmut, Helmut Holtmann, Cord Brakebusch, et al.. (1990). Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.. Journal of Biological Chemistry. 265(24). 14497–14504. 335 indexed citations
9.
Marshak, Gabriel & O. Leitner. (1987). Cytokeratin polypeptides in normal and metaplastic human salivary gland epithelia. Journal of Oral Pathology and Medicine. 16(9). 442–449. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026